Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Antitumour activity of coordination polymer nanoparticles

  • Suárez-García, Salvio
  • Solorzano, Rubén
  • Alibés, Ramón
  • Busqué, Félix
  • Novio, Fernando
  • Ruiz Molina, Daniel
Nanoscale coordination polymers (NCPs) have fascinated researchers over the last years. Their intrinsic theranostic properties of metal ions and organic ligands, the encapsulation of several drugs/biomolecules with excellent yields and the surface functionalisation, enhancing their biocompatibility and targeting, have remarkably impacted in prospective drug delivery alternatives in medicine. Moreover, the properties and characteristics of these nanoparticles (NPs) can be fine-tuned thanks to the synthetic flexibility of coordination chemistry. For all these reasons, the number of examples published has grown exponentially over the last years, embracing different disciplines such as molecular electronics, sensors or nanomedicine, among others. Specifically, significant advances in antitumoural applications are reported, one of the areas where this novel family of NPs has experienced a considerable advance. NCPs have accomplished a high sophistication degree and efficiency as theranostic nanoplatforms (i.e., drug delivery carriers and bioimaging probes) with long residence time in the bloodstream, targeting capacities and remarkable cellular internalisation. In this review, an introduction emphasizing the advantages of NPs for cancer treatment is included. Later on, the most representative examples of NCPs for antitumoural applications are described grouped into six mean representative areas: i) encapsulation approaches, ii) stimuli-responsive NCPs, iii) metal chemotherapy, iv) photodynamic therapy (PDT), v) unconventional therapeutic approaches and vi) theranostics. Particular emphasis is given to understand the encapsulation/release properties of these particles at the nanoscale and their interaction with biological environments, highlighting any limitation and challenges that these systems are facing from a clinical translation perspective and envisioning possible future trends and areas that will deserve further attention for the following years., This work was supported by grants RTI2018-098027-B-C21, PID2019-106403RB-I00 and RED2018-102471-T from the Spanish Government funds and by the European Regional Development Fund (ERDF). The ICN2 is funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa Centres of Excellence programme, funded by the Spanish Research Agency (AEI, grant no. SEV-2017-0706). R. S. thanks the Ministerio de Educación, Cultura y Deporte for the predoctoral grant FPU14/03170. S.S.-G. acknowledges the support from MINECO BES-2015-071492 grant. Special thanks to Dr. Javier Saiz-Poseu from 3D Science Visuals (Instagram: 3dscivisuals) for contributing with graphic design and scientific illustrations.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Conductive properties of triphenylene MOFs and COFs

  • Contreras-Pereda, Noemí
  • Pané, Salvador
  • Puigmartí Luis, Josep
  • Ruiz Molina, Daniel
Triphenylene (TP) based materials have experienced a great expansion in the latest years. TP molecules have interesting optoelectronic properties, arising from the aromatic core, which have been exploited in functional two-dimensional (2D) Metal-Organic Frameworks (MOFs) and Covalent Organic Frameworks (COFs) aside other organic polymers. In this review we summarize synthetic approaches of TP-based 2D MOFs and COFs emphasizing on the resulting morphology, crystalline domains and orientation, proven to have great impact on the properties and performance of these materials in functional devices. Specifically, we report a detailed description on the different TP-based 2D structures detailing the influence of the chemical and crystalline structure on the electronic properties, specially the in-plane and out-of-plane contribution to the electrical conductivity. Finally, we give also attention and present several examples of functional devices made out with these electronic materials with great impact in the literature as well as in future technological applications., This work was supported by grant RTI2018-098027-B-C21 from the Spanish Government funds and by the European Regional Development Fund (ERDF). The ICN2 is funded by the CERCA programme / Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa Centres of Excellence programme, funded by the Spanish Research Agency (AEI, grant no. SEV-2017-0706). N. C.-P. acknowledges the support of fellowship from “laCaixa” Foundation (ID 100010434). The fellowship code is LCF/BQ/ES17/11600012. J. P.-L. acknowledges support from the European Research Council Starting Grant microCrysFact (ERC-2015-STG No. 677020), the Swiss National Science Foundation (project no. 200021_181988), and grant PID2020-116612RB-C33 funded by MCIN/ AEI /10.13039/501100011033. S.P. acknowledges support from the ERC-2017-CoG HINBOTS Grant No. 771565.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?

  • Ruiz Molina, Daniel
  • Mao, Xiaoman
  • Alfonso Triguero, Paula
  • Lorenzo, Julia
  • Bruna, Jordi
  • Yuste, Víctor J.
  • Candiota, Ana Paula
  • Novio, Fernando
Glioblastoma multiforme (GB) is the most aggressive and frequent primary malignant tumor in the central nervous system (CNS), with unsatisfactory and challenging treatment nowadays. Current standard of care includes surgical resection followed by chemotherapy and radiotherapy. However, these treatments do not much improve the overall survival of GB patients, which is still below two years (the 5-year survival rate is below 7%). Despite various approaches having been followed to increase the release of anticancer drugs into the brain, few of them demonstrated a significant success, as the blood brain barrier (BBB) still restricts its uptake, thus limiting the therapeutic options. Therefore, enormous efforts are being devoted to the development of novel nanomedicines with the ability to cross the BBB and specifically target the cancer cells. In this context, the use of nanoparticles represents a promising non-invasive route, allowing to evade BBB and reducing systemic concentration of drugs and, hence, side effects. In this review, we revise with a critical view the different families of nanoparticles and approaches followed so far with this aim., This work was supported by grant RTI2018-098027-B-C21, RTI2018-098027-B-C22, and PID2020-113058GB-I00 funded by MCIN/AEI/10.13039/501100011033, by ERDF A way of making Europe and by PI21/00181 from the Instituto Carlos III. This work was also supported by “Metalfármacos multifuncionales para el diagnóstico y la terapia”, through grant RED2018-102471-T, funded by MCIN/AEI/10.13039/501100011033. The ICN2 and IDIBELL are funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa Centres of Excellence programme, grant SEV-2017-0706, funded by MCIN/AEI/10.13039/501100011033. COST is kindly acknowledged for stimulating scientific discussion and financial support via the Cost Action CA 17140 “Cancer nanomedicine from the bench to the bedside”. A.P.C. received funding from the ATTRACT project funded by the EC under Grant Agreement 777222. This work was also supported by the Centro de Investigación Biomédica en Red-Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN [http://www.ciber-bbn.es/en], CB06/01/0010), an initiative of the Instituto de Salud Carlos III (Spain). The PhD program of X.M. was supported by the La Caixa-Severo Ochoa International PhD Fellowship.